ETHZ

$0.00

(

+0.00%

)
Quote details

stock

ETHZilla Corporation

NASDAQ | ETHZ

17.47

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 20, 2025)

-

Market Cap

-

P/E Ratio

-

EPS

$20.39

52 Week High

$0.65

52 Week Low

HEALTHCARE

Sector

ETHZ Chart

Recent Chart
Price Action

ETHZ Technicals

Tags:

ETHZ Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$58K
Total Revenue $0
Cost Of Revenue $58K
Costof Goods And Services Sold $58K
Operating Income -$6.3M
Selling General And Administrative $4.4M
Research And Development $2M
Operating Expenses $6.3M
Investment Income Net -
Net Interest Income -$51K
Interest Income -
Interest Expense $51K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $190K
Income Before Tax -$6.5M
Income Tax Expense -$296K
Interest And Debt Expense -
Net Income From Continuing Operations -$6.2M
Comprehensive Income Net Of Tax -
Ebit -$6.5M
Ebitda -$6.3M
Net Income -$6.2M

Revenue & Profitability

Earnings Performance

ETHZ Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $13M
Total Current Assets $5.1M
Cash And Cash Equivalents At Carrying Value $4.6M
Cash And Short Term Investments $4.6M
Inventory -
Current Net Receivables $41K
Total Non Current Assets $7.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $7.6M
Intangible Assets Excluding Goodwill $7.6M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $515K
Other Non Current Assets -
Total Liabilities $3.5M
Total Current Liabilities $3.5M
Current Accounts Payable $1.9M
Deferred Revenue -
Current Debt -
Short Term Debt $148K
Total Non Current Liabilities $6.6K
Capital Lease Obligations -
Long Term Debt $6.6K
Current Long Term Debt $148K
Long Term Debt Noncurrent -
Short Long Term Debt Total $155K
Other Current Liabilities $1.4M
Other Non Current Liabilities -
Total Shareholder Equity $9.3M
Treasury Stock -
Retained Earnings -$142M
Common Stock $318
Common Stock Shares Outstanding $915K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.5M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $58K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $8M
Dividend Payout Common Stock $8M
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$6.2M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$58K
Total Revenue $0
Cost Of Revenue $58K
Costof Goods And Services Sold $58K
Operating Income -$6.3M
Selling General And Administrative $4.4M
Research And Development $2M
Operating Expenses $6.3M
Investment Income Net -
Net Interest Income -$51K
Interest Income -
Interest Expense $51K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $190K
Income Before Tax -$6.5M
Income Tax Expense -$296K
Interest And Debt Expense -
Net Income From Continuing Operations -$6.2M
Comprehensive Income Net Of Tax -
Ebit -$6.5M
Ebitda -$6.3M
Net Income -$6.2M

ETHZ News

ETHZ Profile

ETHZilla Corporation Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

ETHZilla Corporation is a clinical-stage biotechnology firm based in Palm Beach, Florida, focused on developing innovative therapeutics for chronic pain, inflammation, fibrosis, and various inflammatory diseases. The company is dedicated to addressing significant unmet medical needs through its advanced pipeline of novel drug candidates, which promise to enhance patient outcomes in underserved therapeutic areas. With a strong commitment to research and development, ETHZilla aims to leverage cutting-edge science to deliver transformative solutions that can reshape treatment paradigms in these critical health domains.

VHAI
-25.00%
$0.00
ADAP
-66.61%
$0.06
BYND
+50.23%
$0.96
CGBS
-39.47%
$0.03
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
REPL
+118.22%
$9.82
AZTR
+14.67%
$0.78
TSLA
+2.46%
$439.31
GSIT
+179.91%
$14.21
HBAN
+0.84%
$15.50
HIMS
-15.84%
$49.78
AXDX
-61.36%
$0.03
ELBM
+35.36%
$2.22
DVLT
+25.14%
$2.24
RANI
+29.87%
$2.13
YDKG
-15.61%
$0.04
KVUE
+8.36%
$15.29
LNKS
+30.35%
$0.73
SOFI
-0.22%
$26.54
ACHR
+6.71%
$11.99
YYAI
+7.35%
$0.12
WTO
-2.85%
$0.06
GDXD
-5.89%
$0.67
GRAB
-1.22%
$5.64
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
VIVK
+11.39%
$0.22
CAN
+25.31%
$2.00
SNAP
-1.41%
$7.65
SRM
+53.27%
$10.30
NEHC
+44.44%
$4.55
NUAI
+30.25%
$5.92
GPUS
+16.37%
$0.37
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
LAES
-1.42%
$6.57
RR
-4.05%
$5.44
CLSK
-2.32%
$19.52
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
CUTR
-10.19%
$0.09
T
-1.19%
$26.02
IONZ
+4.98%
$3.88
RXRX
+18.58%
$6.94
WLGS
-5.57%
$0.04
BULL
-6.29%
$11.01
ETWO
0.00%
$3.30
VBTX
+1.00%
$30.26
DFLI
-7.36%
$1.25
RIVN
+0.92%
$13.03
RDHL
+14.50%
$1.71
BITF
+5.18%
$5.26
AFMD
-34.94%
$0.18
NVTS
+11.45%
$16.34
PBR
+0.69%
$11.64
BURU
+1.13%
$0.34
RIOT
+2.45%
$20.03
SGBX
-1.94%
$3.02
STLA
+3.22%
$10.56
NVDA
-0.06%
$183.09
USAR
+6.49%
$29.53
OKLO
+0.77%
$163.38
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
IVF
-46.30%
$0.75
NAYA
-46.30%
$0.75
SLNH
+5.48%
$4.42
CORZ
-3.40%
$19.00
PLTR
+1.87%
$181.49
GRYP
-10.38%
$1.38
IREN
+0.55%
$61.06
MODV
-25.22%
$0.43
ASST
+6.63%
$0.88
NGD
-7.07%
$6.96
INTC
+3.93%
$38.46
AMCR
+0.12%
$8.15
QS
+3.02%
$15.82
RGTZ
+2.92%
$12.32
CSCO
+1.50%
$70.13
UUUU
+3.01%
$21.69
UAMY
+3.81%
$11.61
YGMZ
-77.70%
$0.20
AMD
+2.56%
$239.05
IONQ
-3.46%
$60.75
RKLB
+5.77%
$70.09
SLDP
+4.96%
$6.34
RZLV
-3.37%
$4.87
SAND
-6.04%
$12.12
SBSW
-11.23%
$11.38
UBER
-0.23%
$92.30
GRNQ
-3.87%
$1.33
NXE
-6.12%
$8.43
SHOT
-74.37%
$0.39
EPWK
-2.14%
$0.07
ZAPP
-46.30%
$0.15
CLF
+16.27%
$15.48
RGTI
-2.11%
$45.40
MRVL
-0.31%
$87.95
AAPL
+2.85%
$259.49
VHAI
-25.00%
$0.00
ADAP
-66.61%
$0.06
BYND
+50.23%
$0.96
CGBS
-39.47%
$0.03
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
REPL
+118.22%
$9.82
AZTR
+14.67%
$0.78
TSLA
+2.46%
$439.31
GSIT
+179.91%
$14.21
HBAN
+0.84%
$15.50
HIMS
-15.84%
$49.78
AXDX
-61.36%
$0.03
ELBM
+35.36%
$2.22
DVLT
+25.14%
$2.24
RANI
+29.87%
$2.13
YDKG
-15.61%
$0.04
KVUE
+8.36%
$15.29
LNKS
+30.35%
$0.73
SOFI
-0.22%
$26.54
ACHR
+6.71%
$11.99
YYAI
+7.35%
$0.12
WTO
-2.85%
$0.06
GDXD
-5.89%
$0.67
GRAB
-1.22%
$5.64
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
VIVK
+11.39%
$0.22
CAN
+25.31%
$2.00
SNAP
-1.41%
$7.65
SRM
+53.27%
$10.30
NEHC
+44.44%
$4.55
NUAI
+30.25%
$5.92
GPUS
+16.37%
$0.37
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
LAES
-1.42%
$6.57
RR
-4.05%
$5.44
CLSK
-2.32%
$19.52
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
CUTR
-10.19%
$0.09
T
-1.19%
$26.02
IONZ
+4.98%
$3.88
RXRX
+18.58%
$6.94
WLGS
-5.57%
$0.04
BULL
-6.29%
$11.01
ETWO
0.00%
$3.30
VBTX
+1.00%
$30.26
DFLI
-7.36%
$1.25
RIVN
+0.92%
$13.03
RDHL
+14.50%
$1.71
BITF
+5.18%
$5.26
AFMD
-34.94%
$0.18
NVTS
+11.45%
$16.34
PBR
+0.69%
$11.64
BURU
+1.13%
$0.34
RIOT
+2.45%
$20.03
SGBX
-1.94%
$3.02
STLA
+3.22%
$10.56
NVDA
-0.06%
$183.09
USAR
+6.49%
$29.53
OKLO
+0.77%
$163.38
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
IVF
-46.30%
$0.75
NAYA
-46.30%
$0.75
SLNH
+5.48%
$4.42
CORZ
-3.40%
$19.00
PLTR
+1.87%
$181.49
GRYP
-10.38%
$1.38
IREN
+0.55%
$61.06
MODV
-25.22%
$0.43
ASST
+6.63%
$0.88
NGD
-7.07%
$6.96
INTC
+3.93%
$38.46
AMCR
+0.12%
$8.15
QS
+3.02%
$15.82
RGTZ
+2.92%
$12.32
CSCO
+1.50%
$70.13
UUUU
+3.01%
$21.69
UAMY
+3.81%
$11.61
YGMZ
-77.70%
$0.20
AMD
+2.56%
$239.05
IONQ
-3.46%
$60.75
RKLB
+5.77%
$70.09
SLDP
+4.96%
$6.34
RZLV
-3.37%
$4.87
SAND
-6.04%
$12.12
SBSW
-11.23%
$11.38
UBER
-0.23%
$92.30
GRNQ
-3.87%
$1.33
NXE
-6.12%
$8.43
SHOT
-74.37%
$0.39
EPWK
-2.14%
$0.07
ZAPP
-46.30%
$0.15
CLF
+16.27%
$15.48
RGTI
-2.11%
$45.40
MRVL
-0.31%
$87.95
AAPL
+2.85%
$259.49

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.